Live Quote · NASDAQLGVNHealthcare· Biotechnology

Longeveron Inc.

$0.69 5.29%($-0.04)
TickerSpark Score
46/100
Weak
65
Valuation
40
Profitability
10
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LGVN research report →

52-Week Range16% of range
Low
$0.47
Current
$0.69
High
$1.80
Company Overviewwww.longeveron.com

About the company

Longeveron Inc. is a biotechnology company currently in the clinical development stage, dedicated to pioneering cell-based therapies. These treatments are designed to address both age-related conditions and various critical, life-threatening illnesses.

CEO
Stephen H. Willard
IPO
2021
Employees
25
HQ
Miami, FL, US

Price Chart

-46.88% · this period
$1.74$1.11$0.48Jul 02Dec 31Jul 02
Valuation
Market Cap
$13.76M
P/E
-0.60
P/S
11.32
P/B
1.07
EV/EBITDA
0.06
Div Yield
0.00%
Profitability
Gross Margin
65.13%
Op Margin
-1881.66%
Net Margin
-1844.49%
ROE
-202.41%
ROIC
-130.35%
Growth & Income
Revenue
$1.20M · -49.87%
Net Income
$-22,704,000 · -42.14%
EPS
$-1.29 · -20.56%
Op Income
$-23,287,000
FCF YoY
-27.12%
Performance & Tape
52W High
$1.80
52W Low
$0.47
50D MA
$0.79
200D MA
$0.74
Beta
-0.38
Avg Volume
462.81K

Get TickerSpark's AI analysis on LGVN

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
May 1, 26Lehr Paul Tother250,000
May 1, 26Willard Stephen Hother500,000
May 1, 26Blass Devinother250,000
May 1, 26Agafonova Nataliyaother250,000
May 1, 26Locklear Lisaother250,000
Apr 1, 26Lehr Paul Tother5,611
Apr 1, 26Agafonova Nataliyaother13,145
Apr 1, 26Locklear Lisaother13,145
Apr 1, 26Willard Stephen Hother4,740
Apr 1, 26Blass Devinother8,633
Coverage · LGVN

Our LGVN coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on LGVN yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate LGVN report →
Internal Compare

Similar companies

Peers in the same neighborhood.